Crizonix (Crizotinib) 250 MG – 60 Capsules

(1 customer review)


Crizotinib, a kinase inhibitor, is used to treat patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) under the following conditions:

  • Tumors are Anaplastic Lymphoma Kinase (ALK)-positive, confirmed by an FDA-approved test.
  • Tumors are ROS1-positive, as detected by an FDA-approved test for gene mutation. These indications are determined based on response rate.
Whatsapp +8801922101029